Cartesian Therapeutics Inc (NAS:RNAC)
$ 35.78 -0.22 (-0.61%) Market Cap: 636.74 Mil Enterprise Value: 545.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Q1 2020 Selecta Biosciences Inc Earnings Call Transcript

May 07, 2020 / 12:30PM GMT
Release Date Price: $90 (-2.91%)
Operator

Good morning, and welcome to the Selecta Biosciences First Quarter 2020 Financial Results Conference Call. (Operator Instructions) This call is being live on the -- webcast live on the Investors and Media section of Selecta's website at www.selectabio.com, and it is being recorded.

For opening remarks, I'd like to introduce Elona Kogan, General Counsel of Selecta. Please go ahead.

Elona Kogan
Selecta Biosciences, Inc. - General Counsel & Corporate Secretary

Thank you, and good morning, everyone. Welcome to our first quarter 2020 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of our website, www.selectabio.com. And our quarterly report on Form 10-Q for the quarter ended March 31, 2020, will be filed later today with the SEC.

Joining me today is Carsten Brunn, our President and Chief Executive Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot